My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Amicus Therapeutics (FOLD)
NASDAQ:FOLD

Amicus Stock Analysis & Ratings

Amicus Stock Analysis Overview

Smart Score
5
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Amicus stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

FOLD

FOLD Stock Stats

Previous Close$11.34
Open$11.11
Bid0 x 0
Ask0 x 0
Today’s Range$10.63 - $11.27
52-Week Range$8.60 - $25.39
Volume1.27M
Average Volume2.31M
Market Cap$3.01B
Beta1.17
P/E Ratio-12.6
EPS-0.90
Earnings DateMar 02, 2022

Company Description

Amicus Therapeutics

Amicus Therapeutics, Inc. engages in the discovery, development, and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.
Sector
Healthcare
Industry
Biotechnology
CEO
John F. Crowley
Employees
483
ISIN
US03152W1099
Address
3675 Market Street, Philadelphia, PA, 19104, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

FOLD FAQ

What was Amicus’s price range in the past 12 months?
Amicus lowest stock price was $8.60 and its highest was $25.39 in the past 12 months.
    What is Amicus’s market cap?
    Amicus’s market cap is $3.01B.
      What is Amicus’s price target?
      The average price target for Amicus is $15.50. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $19.00 ,the lowest forecast is $12.00. The average price target represents 43.52% Increase from the current price of $10.8.
        What do analysts say about Amicus?
        Amicus’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 8 Wall Streets Analysts.
          When is Amicus’s upcoming earnings report date?
          Amicus’s upcoming earnings report date is Mar 02, 2022 which is in 95 days.
            How were Amicus’s earnings last quarter?
            Amicus released its earnings results on Nov 09, 2021. The company reported -$0.19 earnings per share for the quarter, missing the consensus estimate of -$0.176 by -$0.014.
              Is Amicus overvalued?
              According to Wall Street analysts Amicus’s price is currently Undervalued.
                Does Amicus pay dividends?
                Amicus does not currently pay dividends.
                What is Amicus’s EPS estimate?
                Amicus’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Amicus have?
                Amicus has 278,640,000 shares outstanding.
                  What happened to Amicus’s price movement after its last earnings report?
                  Amicus reported an EPS of -$0.19 in its last earnings report, missing expectations of -$0.176. Following the earnings report the stock price went down -3.772%.
                    Which hedge fund is a major shareholder of Amicus?
                    Among the largest hedge funds holding Amicus’s share is Perceptive Advisors LLC. It holds Amicus’s shares valued at 254M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis